泰林生物(300813.SZ)发布前三季度业绩，归母净利润1472.33万元，增长30.13%

Core Viewpoint - Tailin Bio (300813.SZ) reported a decline in revenue for the first three quarters of 2025, while net profit showed significant growth compared to the previous year [1] Financial Performance - The company's operating revenue for the first three quarters was 213 million yuan, representing a year-on-year decrease of 12.08% [1] - Net profit attributable to shareholders of the listed company was 14.72 million yuan, reflecting a year-on-year increase of 30.13% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 13.05 million yuan, which is a year-on-year increase of 21.83% [1] - Basic earnings per share were 0.12 yuan [1]